Regulatory Approval Status: Manufactured under GMP conditions as a registered pharmaceutical intermediate/API; supplied with DMF and Certificate of Analysis support, not marketed as a standalone finished drug product
Indication: Fenamate-class NSAID used as a potent analgesic for acute migraine attacks, dysmenorrhea, rheumatoid arthritis and osteoarthritis
Leave your rating & comment